Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer



Status:Terminated
Conditions:Cancer, Cancer, Chronic Pain, Other Indications
Therapuetic Areas:Musculoskeletal, Oncology, Other
Healthy:No
Age Range:18 - Any
Updated:12/27/2017
Start Date:July 2006
End Date:February 2009

Use our guide to learn which trials are right for you!

A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548; IND # 6370) for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy (Followed by Surgery for Selected Patients)

RATIONALE: Growth factors, such as palifermin, may lessen the severity of mucositis, or mouth
sores, in patients receiving radiation therapy and chemotherapy for head and neck cancer. It
is not yet known whether palifermin is more effective than a placebo in lessening mucositis
in patients receiving radiation therapy and chemotherapy for head and neck cancer.

PURPOSE: This randomized phase III trial is studying palifermin to see how well it works
compared to a placebo in lessening oral mucositis in patients undergoing radiation therapy
and chemotherapy for locally advanced head and neck cancer.

OBJECTIVES:

Primary

- Compare the efficacy of palifermin vs placebo, in terms of burden of acute mucositis
(defined to be 105 days [15 weeks] or less from the start of treatment), in patients
with squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx
undergoing concurrent radiotherapy and chemotherapy.

Secondary

- Compare incidence and time to onset of Grades 3 or 4 oral mucositis in patients treated
with these regimens.

- Compare overall and progression-free survival and time to second primary in patients
treated with these regimens.

OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients
are stratified according to disease stage (III vs IVA or IVB), tumor site (oral cavity or
oropharynx vs hypopharynx or larynx), and radiotherapy technique used on study
(intensity-modulated radiotherapy [IMRT] vs 3-dimensional conformal radiotherapy [3D-CRT]).
Patients are randomized to 1 of 2 treatment arms.

Mucositis, pain, and symptom burden are assessed at baseline, during radiotherapy, and post
radiotherapy. Xerostomia is assessed at baseline, during radiotherapy, and several times
after completion of study therapy.

After completion of study therapy, patients are followed periodically for 10 years.

PROJECTED ACCRUAL: A total of 298 patients will be accrued for this study.

Inclusion Criteria:

1. Pathologically (histologically or cytologically) proven (from primary lesion and/or
lymph nodes) diagnosis of squamous cell carcinoma of the oral cavity, oropharynx,
hypopharynx, or larynx;

2. Patients must have at least 2 mucosal sites of the oral cavity/oropharynx mucosa
assessable by visual transoral inspection that will receive at least 66 Gy;

-2.1 Patients with tumors of the larynx or hypolarynx are eligible only if it is
anticipated that the 2 index sites in the oral cavity/oropharynx mucosa will receive
at least 66 Gy;

3. Patients must be able to be evaluated for the primary endpoint; therefore, patients
must be able to eat at least soft solids and not require a feeding tube for nutrition
or hydration at study entry.

4. Selected Stage III (excluding T1N1MO) or IVA-B (AJCC, 6th edition) at study entry,
including no distant metastases, based upon the following minimum diagnostic workup:

- 4.1 History/physical examination, including documentation of tobacco/alcohol use
and current medications (including opioids/dosing), within 8 weeks prior to
registration;

- 4.2 Chest x-ray (or Chest CT scan) within 6 weeks prior to registration;

- 4.3 MRI or CT scan with contrast of tumor site within 6 weeks prior to
registration;

- 4.4 Assessment of mucositis and xerostomia within 2 weeks prior to registration;

5. Zubrod Performance Status 0-1;

6. Age > 18;

7. Adequate bone marrow function, defined as follows:

- 7.1 Absolute neutrophil count (ANC) > 1,800 cells/mm3 based upon CBC/differential
obtained within 2 weeks prior to registration on study

- 7.2 Platelets > 100,000 cells/mm3 based upon CBC/differential obtained within 2
weeks prior to registration on study

- 7.3 Hemoglobin > 8.0 g/dl based upon CBC/differential obtained within 2 weeks
prior to registration on study (Note: The use of transfusion or other
intervention to achieve Hgb > 8.0 g/dl is acceptable.)

8. Adequate hepatic function with bilirubin < 1.5 mg/dl, AST or ALT < 2 x ULN within 2
weeks prior to registration;

9. Adequate renal function with serum creatinine < 1.5 mg/dl and creatinine clearance
(CC) ≥ 50 ml/min within 2 weeks prior to registration determined by 24-hour collection
or estimated by Cockcroft-Gault formula:

CCr male = [(140 - age) x (wt in kg)]/[(Serum Cr mg/dl) x (72)] CCr female = 0.85 x
(CrCl male)

10. Normal serum calcium or normal corrected serum calcium within 2 weeks prior to
registration; formula for corrected calcium if albumin valued is below normal range:
Corrected calcium (mg/dl) = (4 - [patient's albumin (g/dl)] x 0.8) + patient's
measured calcium (mg/dl);

11. Serum pregnancy test for women of childbearing potential within 2 weeks prior to
registration;

12. Women of childbearing potential and male participants must practice adequate
contraception.

13. Patient agrees to refrain from using all products listed in Section 9.2,
"Non-permitted Supportive Therapy";

14. Patient must sign study specific informed consent prior to study entry.

Exclusion Criteria:

1. Patients with a history of prior head and neck squamous cancer are ineligible;

2. Stage IVC (AJCC, 6th edition) [Any T, Any N, M1] or distant metastases at protocol
study entry; T1N1M0 patients are excluded.

3. Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free
for a minimum of 3 years;

4. Prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a
different cancer is allowable. See Sections 1 and 3.

5. Prior radiotherapy to the region of the study cancer that would result in overlap of
radiation therapy fields;

6. Initial surgical treatment, excluding diagnostic biopsy of the primary site or nodal
sampling of neck disease; radical or modified neck dissection is not permitted.

7. Severe, active co-morbidity, defined as follows:

- 7.1 Symptomatic and/or uncontrolled cardiac disease, New York Heart Association
Classification III or IV (see Appendix II);

- 7.2 Transmural myocardial infarction within the last 6 months;

- 7.3 Acute bacterial or fungal infection requiring intravenous antibiotics at the
time of registration;

- 7.4 Chronic Obstructive Pulmonary Disease exacerbation or other respiratory
illness requiring hospitalization or precluding study therapy at the time of
registration.

- 7.5 Hepatic insufficiency resulting in clinical jaundice and/or coagulation
defects;

- 7.6 Patients known to be sero-positive for hepatitis B virus (HBV) or hepatitis C
virus (HCV);

- 7.7 Patients known to be sero-positive for human immunodeficiency virus (HIV) or
patients with Acquired Immune Deficiency Syndrome (AIDS) based upon current CDC
definition; note, however, that HIV testing is not required for entry into this
protocol. The need to exclude patients with HIV or AIDS from this protocol is
necessary because the treatments involved in this protocol may be significantly
immunosuppressive.

- 7.8 A history of pancreatitis.

8. Collagen vascular disease, such as scleroderma, as this disease is thought to
predispose patients to increased risk for radiation-associated toxicities;

9. Previous treatment with palifermin or other keratinocyte growth factors, such as
velafermin or repifermin;

10. Prior allergic reaction or known sensitivity to any of the agents administered during
dosing, including E. coli-derived products, such as Nutropin®, Neupogen®, Humulin®,
Roferon®; Neumega®, Neulasta®), IntronA®, Betaseron®;

11. Pregnancy or women of childbearing potential and men who are sexually active and not
willing/able to use medically acceptable forms of contraception; this exclusion is
necessary because the treatment involved in this study may be significantly
teratogenic.
We found this trial at
48
sites
1171
mi
from
Burbank, CA
Click here to add this to my saved trials
4100 John R
Detroit, Michigan 48201
800-527-6266
Barbara Ann Karmanos Cancer Institute Karmanos is based in southeast Michigan, in midtown Detroit, and...
841
mi
from
Detroit, MI
Click here to add this to my saved trials
1500 E Duarte Rd
Duarte, California 91010
(626) 256-4673
City of Hope Comprehensive Cancer Center City of Hope is a leading research and treatment...
1152
mi
from
Duarte, CA
Click here to add this to my saved trials
125 Science Dr
Durham, North Carolina 27710
888.275.3853
Duke Comprehensive Cancer Center Leading-edge cancer care and research have been a hallmark of Duke...
1051
mi
from
Durham, NC
Click here to add this to my saved trials
1920 Libal Street
Green Bay, Wisconsin 54307
(920) 433-8889
St. Vincent Hospital Regional Cancer Center Our group of 19 oncologists, including the region's only...
689
mi
from
Green Bay, WI
Click here to add this to my saved trials
600 Moye Boulevard
Greenville, North Carolina 27834
1138
mi
from
Greenville, NC
Click here to add this to my saved trials
200 North Park Street
Kalamazoo, Michigan 49007
(269) 382-2500
West Michigan Cancer Center In 1994, Borgess Health Alliance and Bronson Healthcare Group opened the...
718
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
524 South Park Street
Kalamazoo, Michigan 49007
(269) 341-7654
Bronson Methodist Hospital Our healthcare system serves patients and families throughout southwest Michigan and northern...
718
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
800 NE 10th Street
Oklahoma City, Oklahoma 73104
(855) 750-2273
Oklahoma University Cancer Institute The Peggy and Charles Stephenson Cancer Center is located on the...
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
42 E Laurel Rd # 2545
Voorhees, New Jersey 08043
(800) 826-6737
Cancer Institute of New Jersey at Cooper - Voorhees Cooper University Health Care, the clinical...
1233
mi
from
Voorhees, NJ
Click here to add this to my saved trials
1 Akron General Ave
Akron, Ohio 44307
(330) 344-6000
McDowell Cancer Center at Akron General Medical Center Learning that you or someone you love...
897
mi
from
Akron, OH
Click here to add this to my saved trials
161 North Forge Street
Akron, Ohio 44304
(330) 375-7280
Summa Center for Cancer Care at Akron City Hospital Summa Health System is a leader...
899
mi
from
Akron, OH
Click here to add this to my saved trials
671
mi
from
Anderson, IN
Click here to add this to my saved trials
Auburn, California 95603
1259
mi
from
Auburn, CA
Click here to add this to my saved trials
900 Caton Ave.
Baltimore, Maryland 21229
410-368-6000
St. Agnes Hospital Cancer Center Saint Agnes Hospital is leading Maryland in the battle against...
1144
mi
from
Baltimore, MD
Click here to add this to my saved trials
1227
mi
from
Camden, NJ
Click here to add this to my saved trials
Cameron Park, California 95682
1255
mi
from
Cameron Park, CA
Click here to add this to my saved trials
1274
mi
from
Carmichael, CA
Click here to add this to my saved trials
1297
mi
from
Chico, CA
Click here to add this to my saved trials
1321
mi
from
Edmonton,
Click here to add this to my saved trials
Great Falls, Montana 59405
957
mi
from
Great Falls, MT
Click here to add this to my saved trials
Hermitage, Pennsylvania 16148
955
mi
from
Hermitage, PA
Click here to add this to my saved trials
572
mi
from
Houston, TX
Click here to add this to my saved trials
1721 S Stephenson Ave
Iron Mountain, Michigan 49801
(906) 774-1313
Dickinson County Healthcare System The vision of Dickinson County Healthcare System is to provide quality...
754
mi
from
Iron Mountain, MI
Click here to add this to my saved trials
Johnson City, Tennessee 37604
857
mi
from
Johnson City, TN
Click here to add this to my saved trials
1521 Gull Rd
Kalamazoo, Michigan 49048
269) 226-7000
Borgess Medical Center At Borgess, healing is our calling. This is the place where people...
719
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
3100 Shore Dr.
Marinette, Wisconsin 54143
715.735.6621
Bay Area Cancer Care Center at Bay Area Medical Center The Bay Area Cancer Care...
730
mi
from
Marinette, WI
Click here to add this to my saved trials
Monroeville, Pennsylvania 15146
983
mi
from
Monroeville, PA
Click here to add this to my saved trials
Natrona Heights, Pennsylvania 15065
987
mi
from
Natrona Heights, PA
Click here to add this to my saved trials
4701 Ogletown-Stanton Road
Newark, Delaware 19713
302-623-4450
CCOP - Christiana Care Health Services Christiana Care's Cancer Research Program is part of a...
1195
mi
from
Newark, DE
Click here to add this to my saved trials
2809 Denny Ave
Pascagoula, Mississippi 39581
228-809-5251
Regional Cancer Center at Singing River Hospital The Regional Cancer Center team at Singing River...
736
mi
from
Pascagoula, MS
Click here to add this to my saved trials
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Cancer Center The Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive...
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Roseville, California 95661
1269
mi
from
Roseville, CA
Click here to add this to my saved trials
840
mi
from
Royal Oak, MI
Click here to add this to my saved trials
1280
mi
from
Sacramento, CA
Click here to add this to my saved trials
Sacramento, California 95819
1280
mi
from
Sacramento, CA
Click here to add this to my saved trials
1200 6th Ave N
Saint Cloud, Minnesota 56303
(320) 252-5131
CentraCare Clinic - River Campus CentraCare Health is a not-for-profit health care system that provides...
571
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
930
mi
from
Salem, OH
Click here to add this to my saved trials
5777 E Mayo Blvd
Scottsdale, Arizona 85259
(480) 515-6296
Mayo Clinic Scottsdale Mayo Clinic Arizona was the second Mayo practice to be established outside...
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Somerset, Pennsylvania 15501
1016
mi
from
Somerset, PA
Click here to add this to my saved trials
1800 E Park Ave
State College, Pennsylvania 16803
(814) 231-7000
Mount Nittany Medical Center Mount Nittany Medical Center is a 260-bed acute care facility offering...
1083
mi
from
State College, PA
Click here to add this to my saved trials
Torrance, California 90505
1179
mi
from
Torrance, CA
Click here to add this to my saved trials
Vacaville, California 95687
1309
mi
from
Vacaville, CA
Click here to add this to my saved trials
1233
mi
from
Vineland, NJ
Click here to add this to my saved trials
Wheeling, West Virginia 26003
933
mi
from
Wheeling, WV
Click here to add this to my saved trials
Wooster, Ohio 44691
872
mi
from
Wooster, OH
Click here to add this to my saved trials